Neuronetics, Inc.
STIM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $184 | $231 | $226 | $59 |
| - Cash | $34 | $11 | $20 | $18 |
| + Debt | $25 | $81 | $83 | $83 |
| Enterprise Value | $174 | $301 | $289 | $123 |
| Revenue | $37 | $38 | $32 | $22 |
| % Growth | -2.1% | 19.2% | 42.2% | – |
| Gross Profit | $17 | $18 | $16 | $15 |
| % Margin | 45.9% | 46.6% | 49.2% | 66.2% |
| EBITDA | -$6 | -$7 | -$10 | -$11 |
| % Margin | -17.3% | -18.8% | -30.8% | -47.5% |
| Net Income | -$9 | -$10 | -$13 | -$13 |
| % Margin | -24.3% | -26.6% | -39.6% | -56.3% |
| EPS Diluted | -0.13 | -0.15 | -0.21 | -0.33 |
| % Growth | 13.3% | 28.6% | 36.4% | – |
| Operating Cash Flow | -$1 | -$4 | -$17 | -$9 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$4 | -$17 | -$9 |